What is pharmacogenomics? What research is taking place in pharmacogenomics right now? What role will it play in patient care as we try to live longer, even following cancer, diabetes, heart & stroke? Pharmacogenomics is an emerging science that integrates the patient’s genomic data so as to personalize treatment and thereby improve the effectiveness and reduce the toxicity of medications in such areas as cardiovascular disease (including diabetes and hypertension), cancer, neuroscience and mental health, and pediatrics.

• Dr Michael Phillips, Director of Pharmacogenomics, Génome Québec and Montreal Heart Institute and Associate Professor, University of Montreal.